Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins

Human immunodeficiency virus (HIV) proteins Tat and gp120 have been implicated in the pathogenesis of HIV dementia by various mechanisms, including down-regulation of excitatory amino acid transporter-2 (EAAT2), which is responsible for inactivation of synaptic glutamate. Recent work indicates that beta-lactam antibiotics are potent stimulators of EAAT2 expression. The authors treated mixed human fetal neuronal cultures with recombinant gp120 or Tat, in the presence or absence of ceftriaxone, and determined neurotoxicity by measuring mitochondrial membrane potential and neuronal cell death. Ceftriaxone produced dose-dependent attenuation of the neurotoxicity and neuronal cell death caused by both viral proteins. This study demonstrates that this class of drugs may have therapeutic efficacy in HIV dementia.

[1]  P. Fisher,et al.  β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression , 2005, Nature.

[2]  J. Rothstein,et al.  Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. , 2003, Virology.

[3]  Bruce J Brew,et al.  Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy , 2003, AIDS.

[4]  D. Amantea,et al.  Caspase-1 inhibitors abolish deleterious enhancement of COX-2 expression induced by HIV-1 gp120 in human neuroblastoma cells. , 2003, Toxicology letters.

[5]  N. Sacktor,et al.  Human immunodeficiency virus-associated dementia: An evolving disease , 2003, Journal of NeuroVirology.

[6]  N. Sacktor.  The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.

[7]  P. Mulholland,et al.  Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor , 2002, Brain Research.

[8]  Markus Bickel,et al.  HIV‐Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy , 2002, Journal of acquired immune deficiency syndromes.

[9]  M. Mattson,et al.  HIV‐1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity , 2001, Journal of neurochemistry.

[10]  M. Mattson,et al.  Estrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaine , 2001, BMC Neuroscience.

[11]  A. Bansal,et al.  Neurotoxicity of HIV-1 proteins gp120 and Tat in the rat striatum , 2000, Brain Research.

[12]  R. Swanson,et al.  Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.

[13]  R. Szymocha,et al.  Human T-Cell Lymphotropic Virus Type 1-Infected T Lymphocytes Impair Catabolism and Uptake of Glutamate by Astrocytes via Tax-1 and Tumor Necrosis Factor Alpha , 2000, Journal of Virology.

[14]  Melina V Jones,et al.  Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.

[15]  J. Billaud,et al.  Replication rate of feline immunodeficiency virus in astrocytes is envelope dependent: implications for glutamate uptake. , 2000, Virology.

[16]  F. Fonnum,et al.  3-Nitropropionic acid: an astrocyte-sparing neurotoxin in vitro , 1999, Brain Research.

[17]  M. Robinson.  Review Article The family of sodium-dependent glutamate transporters: a focus on the GLT-1/EAAT2 subtype , 1998, Neurochemistry International.

[18]  J. Billaud,et al.  Effects of feline immunodeficiency virus on astrocyte glutamate uptake: implications for lentivirus-induced central nervous system diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Nath,et al.  The Tat Protein of HIV-1 Induces Tumor Necrosis Factor-α Production , 1997, The Journal of Biological Chemistry.

[20]  A. Nath,et al.  The Tat protein of HIV-1 induces tumor necrosis factor-alpha production. Implications for HIV-1-associated neurological diseases. , 1997, The Journal of biological chemistry.

[21]  A. Nath,et al.  Molecular Determinants for Cellular Uptake of Tat Protein of Human Immunodeficiency Virus Type 1 in Brain Cells , 1996 .

[22]  J. Antel,et al.  Expression of Tumor Necrosis Factor α (TNFα) and Interleukin 6 (IL‐6) mRNA in Adult Human Astrocytes: Comparison with Adult Microglia and Fetal Astrocytes , 1996 .

[23]  D. Magnuson,et al.  Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic , 1996, Journal of virology.

[24]  I. Elovaara,et al.  Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia , 1995, AIDS.

[25]  J. Church.  HIV-1 INFECTION OF SUBCORTICAL ASTROCYTES IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM , 1995, Pediatrics.

[26]  R. Brownstone,et al.  Human immunodeficiency virus type 1 tat activates non—N‐methyl‐D‐aspartate excitatory amino acid receptors and causes neurotoxicity , 1995, Annals of neurology.

[27]  S. Lipton.  AIDS‐Related Dementia and Calcium Homeostasis a , 1994, Annals of the New York Academy of Sciences.

[28]  M. Louder,et al.  Overexpression of nef as a marker for restricted HIV‐1 infection of astrocytes in postmortem pediatric central nervous tissues , 1994, Neurology.

[29]  J. Sodroski,et al.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Sande,et al.  Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. , 1984, The American journal of medicine.

[31]  A. Schousboe,et al.  Novel neuron-related regulatory mechanisms for astrocytic glutamate and GABA high affinity uptake , 1983, Neuroscience Letters.

[32]  Yaakov Stern,et al.  HIV-associated cognitive impairment before and after the advent of combination therapy , 2011, Journal of NeuroVirology.

[33]  P. Fisher,et al.  Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: Potential role in neuropathogenesis , 2011, Journal of NeuroVirology.

[34]  J. Nalbantoglu,et al.  Expression of tumor necrosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. , 1996, Journal of neuropathology and experimental neurology.

[35]  E. Tramont,et al.  The human immunodeficiency virus. , 1991, Dermatologic clinics.

[36]  A. Harel-Bellan,et al.  Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. , 1989, Proceedings of the National Academy of Sciences of the United States of America.